Boughton Soleil 4
4 · Hims & Hers Health, Inc. · Filed Mar 18, 2026
Research Summary
AI-generated summary of this filing
HIMS Chief Legal Officer Soleil Boughton Sells 4,812 Shares
What Happened
- Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc. (HIMS), sold 4,812 shares of HIMS stock on March 17, 2026. The shares were sold at $24.69 each for total proceeds of approximately $118,808. This was a sale (not a purchase), which is often routine insider selling rather than a direct bullish signal.
Key Details
- Transaction date and price: March 17, 2026 — 4,812 shares sold at $24.69 per share.
- Total value: ~ $118,808.
- Shares owned after transaction: Not provided in the information supplied.
- Footnote: The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025 (pre-arranged trading plan).
- Filing timeliness: Reported on March 18, 2026 for a March 17, 2026 transaction — appears timely.
Context
- Trades under a Rule 10b5-1 plan are pre-scheduled and can reflect previously arranged instructions rather than contemporaneous insider views. Sales are common for liquidity or diversification and do not necessarily indicate management’s view of company prospects.
Insider Transaction Report
Form 4
Boughton Soleil
Chief Legal Officer
Transactions
- Sale
Class A Common Stock
[F1]2026-03-17$24.69/sh−4,812$118,808→ 308,831 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 18, 2025 by the Reporting Person.
Signature
/s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton|2026-03-18